Germline variation in genes that encode the human T cell receptors (TCRs) may have an important influence in shaping the immune T cell repertoire. In this report we describe a frequent null allele of the human VB18 gene, resulting from a nucleotide substitution that creates a stop codon (CGA~ Approximately 11% of the population tested was homozygous for this null allele, indicating that this is a frequent "hole in the repertoire" We confirmed that there is a greatly reduced (undetectable) level of V318 mKNA in peripheral blood lymphocytes from an individual homozygous for this null allele. In addition, all heterozygous individuals expressed detectable levels of only the functional V/318 allele in their peripheral blood lymphocytes. Two other DNA polymorphisms were identified in VB18, one of which would result in an amino acid substitution in an expressed V~18 gene. Genotypes for all three of these V/318 DNA polymorphisms were determined in a group of unrelated individuals. Statistical analyses of the associations between alleles of the V318 polymorphisms and those of other DNA polymorphisms in the TCR 3 locus suggested a close physical proximity between the VB18 gene and the 3' end of the C~2 region. This localization of human V318 had been previously predicted by the sequence homology between human V~18 and mouse VB14, a V gene segment previously mapped to 3' of the mouse C3 genes. We confirmed this localization of the human V318 gene by isolating a cosmid done that contains both the V318 and C~2 gene segments. Mapping by restriction enzyme digestion and by the polymerase chain reaction indicated that the V318 gene segment is approximately 9 kb 3' of the C32 gene, making this the only known human V3 gene 3' of the C3 region.
Germline variation in genes that encode the human T cell receptors (TCRs) may have an important influence in shaping the immune T cell repertoire. In this report we describe a frequent null allele of the human VB18 gene, resulting from a nucleotide substitution that creates a stop codon (CGA~ Approximately 11% of the population tested was homozygous for this null allele, indicating that this is a frequent "hole in the repertoire" We confirmed that there is a greatly reduced (undetectable) level of V318 mKNA in peripheral blood lymphocytes from an individual homozygous for this null allele. In addition, all heterozygous individuals expressed detectable levels of only the functional V/318 allele in their peripheral blood lymphocytes. Two other DNA polymorphisms were identified in VB18, one of which would result in an amino acid substitution in an expressed V~18 gene. Genotypes for all three of these V/318 DNA polymorphisms were determined in a group of unrelated individuals. Statistical analyses of the associations between alleles of the V318 polymorphisms and those of other DNA polymorphisms in the TCR 3 locus suggested a close physical proximity between the VB18 gene and the 3' end of the C~2 region. This localization of human V318 had been previously predicted by the sequence homology between human V~18 and mouse VB14, a V gene segment previously mapped to 3' of the mouse C3 genes. We confirmed this localization of the human V318 gene by isolating a cosmid done that contains both the V318 and C~2 gene segments. Mapping by restriction enzyme digestion and by the polymerase chain reaction indicated that the V318 gene segment is approximately 9 kb 3' of the C32 gene, making this the only known human V3 gene 3' of the C3 region.
A diverse repertoire of TCKs is generated by a variety of somatic mechanisms, including the random rearrangement of gene segments, N region diversification, and junctional diversity. In addition to these somatic effects, allelic variations arising from DNA polymorphisms in the TCR genes also contribute to germline diversity in the population (1) . In the past, RFLPs detected with probes from TCR V genes were used as indirect measures ofDNA polymorphism within the V genes (2-6). More recently, however, direct sequence analysis has demonstrated the presence of germline DNA polymorphisms in the TCR that result in amino acid substitutions. Specifically, Robinson (7) has reported a polymorphism in the V31 gene segment that results in a change from glutamine to histidine, while Li et al. (8) reported two polymorphisms in the V36.7 gene that result in a serine to arginine and also a glycine to glutamic acid substitution. Although the ultimate impact of these or other allelic variations on the TCR repertoire remains to be deteTmined, the analysis of TCR polymorphisms may provide a greater understanding of the potential relationship between DNA polymorphisms in the TCR and susceptibilities to certain autoimmune diseases (reviewed in references 1 and 9).
To further assess the extent of TCR germline polymorphism, we have compared the sequence of TCR V gene segments from multiple individuals. In this study, we report a striking example of a DNA polymorphism in the VB18 gene that results in the introduction of a termination codon (the VB18 gene has also been referred to as the V/320 gene in another nomenclature by Kimura et al. [ga] ). 11% of the individuals analyzed were homozygous for this null allele, and therefore could not express a functional V318 protein product. Analysis of VB18 expression using RNA from PBL confirmed this relationship between V318 RNA message and the stop codon. Additionally, we have also obtained the entire genomic sequence of the V~18 gene, and have determined its physical location to be at the 3' end of the C region genes.
This localization is opposite of other known human Vii genes, but is syntenic with the location of a homologous TCR V gene segment (VB14) previously mapped in the mouse.
Materials and Methods
Human DNA and RNA. A pand of DNAs isolated from the lymphoblastoid cell lines of six unrelated Caucasians was used for polymorphism screening, and was kindly provided by R. A. Gatti. The DNA of 76 Caucasian parents and certain families from Centre d'Etude du Folyrnorphisme Humaine (CEPH) (10), pedigrees were used for polymorphism typing. For the V1518 expression analysis, RNA was isolated from PHA-stimulated PBL from several small families (kindly provided by R. Spielman, University of Pennsylvania, PhiLadelphia, PA) using the acid guanidinium thiocyanatephenol-chloroform extraction method (11) .
Oh'gonudeotide~ Amplification primers and ligafion probes were synthesized using a DNA synthesizer (384 or 391; Applied Biosystems, Inc., Foster City, CA). The sequences of amplification primers and ligation probes used in polymorphism typing of the Vt518 gene segment are shown in Table 1 . The 5' allde-speciiic ligation probes were biotinylated as previously described (12) , and the adjoining 3' reporter probes were phosphorylated using "5'-phosphate-on" according to the manufacturer's instructions (Clonetech, Palo Alto, CA). Ligation probes were purified by reverse-phase HPLC, and the phosphorylated 3' reporter probes were enzymatically labeled with digoxigenin as previously described (13) .
DNA Amplification. DNA samples were amplified by the PCR. For determining the Vf118 genotypes by restriction enzyme digestion, PCR was performed using a DNA thermal cycler (PerkinElmer Cetus, Emeryvilh, CA) in a reaction mix containing reaction buffer (Amersham Corp., Arlington Heights, IL), nucleotides (final concentration, 20 #M each), DNA polymerase (Hot Tub; Araersham Corp.) (final concentration, 10 U/ml), 0.3 IzM each of primer Vfl18-3 and Vfl18-4 (Table 1) , and 10-100 ng of genomic DNA. The amplification profile was 35-40 cycles of 1 rain at 94~ 1 min at 60~ and 2 rnin at 72~
For determining the Vf118 genotypes by OLA, DNA samples were amplified in a 96-well microtiter plate thermal cycler (MJ Research, Watertown, MA). Genomic DNA (10 rig) was mixed with a standard PCR buffer (10 mM Tris-HC1, pH 8.3, 50 ram KC1, 1.5 mM MgClz, and 0.001% gdatin) containing 40 ~M of each of the four deoxynucleotide triphosphates, 0.5 ~M of each primer, and 10 U/ml of Taq polymerase (Perkin-Elmer Cetus) (14) . The amplification profile was 40 cycles of 20 s at 93~ 40 s at 55~ and 90 s at 72~
For PCR-based mapping of the H29 cosmid, 50 ng of cosmid DNA was mixed with the same mixture of PCR buffer, nucleotides, and enzyme as described directly above for amplifying DNA in a 96-wall format. The primer pair used for amplification was 5'-CTGITI~CCIGAAGATTGAG-3' (3' end of C~2) and 5'-ACT-GGGTGGAGGATAITIGTAAG-3' (3' end of V1518). This mix was then subjected to 40 cycles of 1 min at 93~ I min at 55~ and 2 rain at 72~ in a DNA thermal cycler (Perkin-Elmer Cetus). The amount of time at 72~ was extended by 5 s after each cycle and is essential to amplifying larger DNA products.
DNA Sequencing. For purposes of DNA sequencing, a largescale PCR (200/~1) was performed according to the conditions described above. To eliminate an additional manipulation, mineral oil was not used during the amplification so that ethanol p~'ipitation was done in the same tube as used for amplification. The concentrated PCR products were purified by electrophoresis through 1% low-mehing point agarose (Bethesda Research Laboratories, Gaithersburg, MD), and the amplified products excised from the gel 10 ~1 of the PCR product in the gel slice was used directly as the template for sequencing in 96-well assay plates using the Sequenase sequencing kit (U.S. Biochemical Corp., Cleveland, OH) (15) . The sequencing primers used were the same as those used for the original amplification. Sequence from the VB18 gene region was obtained using the H29 cosmid. Sequence-specific oligonucleotide primers were used to sequence across both strands of the cosmid template ('~,2 ~g of cosmid DNA template per labeling reaction). Sequencing was done using the Sequenase sequencing kit, and the annealing and radiolabeling steps were performed at 37~ (15) .
Restriction Digestion Analysis. R~striction digestion of the PCR products was performed without further purification of the DNA. 10 ~1 of the amplified DNA was digested with 10 U of either KpnI or Sau3A (Bethesda Research Laboratories). Only the addition of BSA (final concentration, 100 ~g/ral) was necessary for complete digestion with KpnI, whereas addition of the manufacturer's 10 x digestion buffer was required for digestion with San3A. Restriction enzyme-digested PCR products were subjected to electrophoresis in a 3% agarose gel (including 2% Nusieve agarose; FMC Bioproducts, Rockland, ME) containing ethidium bromide, and visualized by UV iUumination.
Oligonucleotide Ligation Assay (OLA). 1 Analyses of amplified DNA saraples using primers V~18-1 and -2 for each of the V1318 polymorphisms were performed using an OLA detection system previously described in detail (13, 14) . In this assay, each sample was analyzed by a ligation reaction for each allele. Each reaction contained one of the 5' biotinyhted probes specific for that allelic form of the polymorphism, the common 3' reporter probe labeled with digoxigenin, an aliquot of the amplified DNA target, and T4 DNA ligase. If the probes were hybridized to a perfectly matched target, the biotinyhted allele specific and reporter probes were joined by the ligase. To determine whether the ligation reaction had been successful, the reaction was transferred to a streptavidin plate to capture the biotinylated probe. The plate was washed and then assayed for the presence of the covalently attached reporter molecule using an enzyme-linked immunoassay system (13) .
Cosmid Identification and Restriction Digest Mapping. A human cosmid library constructed in a modified pWE15 vector (16) and containing 15 genome equivalents was screened for V~18. The cosmid H29 was identified by hybridization (final stringency was 0.Sx SSC at 65~ to a PCR-amplified V~18 gene segment that had been cloned into the M13 phage. The H29 cosmid was mapped with EcoRI, HindlII, BamHI, and XbaI using a standard protocol of partial digestion, and then sequential hybridization with vectorspecific oligonudeotides (final stringency wash of6x SSC at 65~ and to TCR Cfl and Vf118 probes.
V~18 RNA Expression. For PCR analysis of RNA, eDNA was synthesized from 1-2 ~g of total RNA by random hemmer priming using a eDNA synthesis kit (Amersham Corp.). Approximately 25 ng of the eDNA was PCR amplified with 25 cycles using a 5' Vf118 and 3' Cfl together with a 5' and 3' C~ primer pair, as listed in Fig. 6 , b and c, legends. The products were subjected to dectrophoresis at 150 V through 2% agarose and vacuum blotted with 0.4 N NaOH onto Genetran nylon membrane (Plasco, Marlboro, MA). The membrane was hybridized overnight to a Cfl and CoL DNA probe that were 32p radiolabded separately by random priming. These probes had been combined as a 50:50 mixture based on the amount of incorporated 3zp. The hybridized blot was then washed several times up to a final stringency of0.1x SSC at 65~ The PCK products were detected by autoradiography.
Linleage Disequilibrium Analysis. Statistical analysis of linkage disequilibrium between loci was tested using the Q statistic (17) . This statistic measures the total linkage disequilibrium between the alleles at two loci by summating the differences between the observed frequencies of the alhle combinations and those frequendes expected if one assumed random association of alleles at the two loci. Linkage disequilibrium was also assessed using a normalized measure for disequilibrium, D' (18) , which describes the extent of disequilibrium in terms of the fraction of maximum (• 1.0) linkage disequilibrium possible for that locus pair. Since genetic phase was not established, individuals who were heterozygous at both loci in a pair-wise comparison were not included in the linkage disequilibrium calculation.
Results
Genomic Sequence of the Vff18 Region. To obtain the genomic sequence of the human V/318 region, a cosmid (H29) was isolated by hybridization to a V/~18 probe. Using a series of primer-directed sequencing walks along both strands of the cosmid DNA, the entire V/318 coding sequence was obtained as listed in Fig. 1 . This sequence extends from the leader region, through the first intron and the u gene segment, and ends within the 3' noncoding sequence. The 3' noncoding sequence also includes the recombination signal (heptamer-nonamer sequences) for somatic DNA rearrangement. One of the interesting features of the human V~18 gene sequence is its similarity to mouse V/~14 (19) . This similarity across species is 77% in the coding regions, and 63% overall.
Identification of Sequence Polymorphisms in the Human VB18
Gene Direct sequencing of the amplified germline V/~18 gene segment from multiple persons revealed three DNA polymorphisms in the u gene segment. The positions of the DNA polymorphisms in the V/~18 gene segment are shown in Pig. 1. All three polymorphisms were single nucleotide substitutions involving C to T base transitions. From the amino acid translations, two polymorphisms, one at nudeotide 524 and the other at nucleotide 620, would have significance with regard to the V/~18 protein product. Most importantly, the polymorphism at position 524 leads to the introduction of a stop codon in the V/318 gene sequence. The nucleotide substitution at position 620 would result in a proline to serine amino acid substitution in the gene product. V~18 polymorphisms were determined for a larger group of individuals. First, according to the DNA sequences surrounding the polymorphisms at nucleotide positions 524 and 620 ( Fig. 1) , these polymorphisms would result in altering restriction enzyme recognition sites. The base change at position 524 alters a KpnI restriction site, and the DNA polymorphism at position 620 changes a San3A restriction site, as demonstrated in Fig. 2 . Genotypes for all three V~18 polymorphisms were obtained using the semi-automated OLA typing system. Analysis of the inheritance patterns for these three DNA polymorphisms revealed proper Mendelian segregation, as shown in Fig. 3 . The segregation of the V818 genotypes was completely compatible with cosegregation (i.e., no recombinants) with haplotypes of the TCR ~ chain previously determined in these individuals (6) . Within our tested population (152 chromosomes), the nudentide changes at positions 524 and 620 had identical allde frequencies of 68% for the C substitution and 32% for the T substitution. 11% of the individuals tested were homozygous for the T substitution at nudeotide 524, and therefore, based on the presence of the stop codon, these 11% of the individuals would not produce a functional V:/18 prorein product. The allde frequency for the silent base substitution at nucleotide 661 was slightly different from those found for the other two polymorphisms (524 and 620), i.e., at position 661 the allele frequency for the C substitution was 53% and the T substitution was 47%. Even though one of the substitutions, 524, leads to a stop codon, the genotype distributions for all three polymorphisms were consistent with Hardy-Weinberg equilibrium.
Genotyping of the Vff18 Polyraorphbms. Genotypes for the #etLeuCysSerLeuLerAlaLeuLeuLeuGlyThrPhePhe
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Linkage Disequilibrium Analysis. We statistically examined the extent of association between alldes of the V/~18 polymorphism(s) and alleles of other previously reported TCR DNA polymorphisms ( Table 2) . Because of complete linkage disequilibrium among the three point mutations within the V~18 gene (D' --1.00), only three DNA haplotypes were observed (as shown in Fig. 1 ). The extent of linkage disequilibrium was also measured between the V~18 polymorphisms and other bialhlic polymorphisms previously studied in this same population of CEPH parents (6, 14) . Although the alleles of the V~18 polymorphisms did not show statistical assodation with other V~ gene polymorphisms (Table 2) , polymorphisms at the 3' end of the TCR ~ gene complex (C~2 region) were significantly nonrandomly associated with the 524 and 620 V~18 polymorphism(s) (p <0.0001). The order of the polymorphisms compared in this table (top to bottom) is the same as the physical order of the polymorphisms along the chromosome (centromere to telomere) (6, 14) . * The VJ518 position 524 and 620 polymorphisms are synonymous for this analysis since there was a singular correspondence between alleles at these lod (haplotypes, 86; D', 1.0; Q, 86.0).
* For D', a value of 1.00 (or -1.00) indicates maximum linkage disequilibrium; a value of 0.0 would indicate complete random association between the loci. $ For the Q statistic (x 2 distribution, 1-degree freedom), Q >15 corresponds to p <0.0001, which rejects the null hypothesis of random association between the alleles at that pair of loci. (Table 2) , we sought to confirm the suggested 3' location of the V/~18 gene relative to CB2. The H29 cosmid that contained VB18 was tested for hybridization to 22 other V/~ families and CB. Only hybridization to a C/3 probe was detected. PCtL was used to confirm that this cosmid contained both the V/318 and C/3 genes. Physical mapping of the H29 cosmid with four restriction enzymes and hybridization with V/318 and C~ probes indicated that the VB18 gene was located within 15 kb of the C/~2 gene (Fig. 4) . Previous studies have shown that the mouse V/314 gene (gene counterpart of human VB18) has an opposite transcriptional orientation to that of other VB genes as well as the D, J, and C gene segments (20) . By using PCtL with the H29 cosmid, we have determined the transcriptional orientation of human VB18 relative to the C/32 gene segment. DNA amplification with a primer located just 3' of the end of the CB2 gene, in combination with a primer located just downstream of the VB18 gene, indicated that the V/318 gene segment is located ~9 kb 3' of the C/32 gene (Fig. 5 ). Since these PCtL primers must face each other to amplify the intervening DNA sequence, these data also indicate that the transcriptional orientation for human V/318 is opposite to that of the C/~2 gene, and therefore similar to the orientation of the mouse VB14 and CB2. It is worth noting that several different pairs of amplification primers from the 3' end of the CB2 gene and the 3' end of the V/318 gene could be used to obtain a similarly sized PCR product from cosmid DNA (data not shown). In addition, we were also able to sequence the ends of the 9.5-kb PCR product (Fig. 5 ) in low-melt agarose (see Materials and Methods), which verified the origins of this PCIL product, i.e. C/~2 at the 5' end and V/~18 at the 3' end (data not shown).
V~18 RNA Expression in Peripheral Blood. As a result of the null allele for VB18 in the population, we sought to confirm the importance of this polymorphism in the expression level of V/318 in individuals homozygous for the V/~18 stop codon. Several members from three families were tested by KpnI restriction enzyme analysis of genomic DNA for the V/~18 null allele (KpnI-). Representatives of each of the three genotypes were identified (Fig. 6 A) and PCtL was used to amplify the V/318 RNA (cDNA) from all these individuals. Based on the intensity of the V/318 PCtL product, and the control Cot product in each lane, V~IS-CB message was The rearranged V1318 gene was amplified from cDNA by PCR using the forward primer V/318-3 and a reverse C/5 primer (5'-GGCAGACAGGAC-CCCTTG-Y); the Cot primer pair listed above was also included, The PCR products were digested with KpnI restriction enzyme to confirm that the V/318 null allele (no KpnI site) was not expressed. As a control for the VB18-CB KpnI-allele, the outer lanes (-) contain the PCR product to which KpnI enzyme was not added. The Cot PCK-positive controls in each lane are not shown. detected in the peripheral blood of all individuals, except the person homozygous for the stop codon (Fig. 6 B) . As even stronger evidence of the relationship between the stop codon and V/318 expression, the amplified V/318-C~ message was digested with KpnI ( Fig. 6 C) . The results show that in the eight individuals studied who possessed the null allele (either heterozygous or homozygous individuals), only the V/~18 KpnI + allele was expressed at detectable levels in the peripheral blood.
Discussion
Alldic variation in the germline DN ', of the TCR genes has been suspected to influence the expreb ed TCR repertoire by altering amino acids that change the TC.Vs ability to recognize antigen and/or MHC. DNA polymorphisms in TCR genes could change the expressed T cell repertoire either qualitatively or quantitatively through the process of donal selection and expansion in the thymus or periphery. It is also possible that DNA polymorphisms could influence the quan-tity of an expressed TCK protein by altering regulatory elements, or through translational changes such as creating a stop codon. The potential for functional relevance of TCR polymorphisms has been the basis for many disease association studies that have compared the frequency of various TCR DNA polymorphisms in autoimmune and control populations (reviewed in references 1 and 9).
In this study, we describe an extreme example of a functionally relevant DNA polymorphism that results in the presence of a stop codon in the V/318 gene segment. This polymorphism was present in 54% of the population that we studied. Importantly, 11% of the individuals tested were homozygous for this null allele, indicating a lack of cell surface expression of the V/318 TCR protein. Coincidentally, there were two other DNA polymorphisms in the VB18 gene, one of which would have resulted in an amino acid change from proline to serine, in the absence of the stop codon.
The observation of complete allelic association between the V/318 polymorphisms could have implications in terms of the origins of these polymorphisms. Since the V/318 alleles at positions 524 and 620 were correlated completely, this could be due to the simultaneous "creation" of the polymorphisms in a single ancestral genetic event. A more speculative but immunological explanation for the complete allelic correlation is evolutionary selection at the protein level since the alleles of both polymorphisms would affect expression and possibly structure. At present time, whenever the serine residue is coded for at the second polymorphic site, the termination codon is encoded at the first polymorphic site. The serine/proline substitution site would occur within the fourth hypervariable region in the TCK/3 chain (21) and might be involved in antigen/MHC contact. Based on the location of this amino acid substitution, and the radical nature of the substitution (22) , generous speculation might suggest that the V/318 haplotype with the stop codon and serine residue has been selected to prevent protein expression of the V/318 with a serine residue at this position.
The strong disequilibrium between the C/3-KpnI site (C/32-5; Table 2 ) and the V/318 polymorphisms has relevance to disease association studies since previous studies that have used the C/3-KpnI KFLP have therefore indirectly measured the V/318 polymorphism association with systemic lupus erythematosus, multiple sclerosis, and myasthenia gravis (23, 24) . Also, the lack of any detectable disequilibrium between the V/318 polymorphisms and the C/3-BgllI RFLP (CB2-1), as well as the other more distant 5' V/3 KFLPs (Table 2) , implies that the many positive disease associations found with those RFLPs (1, 9) cannot be directly explained by the V/318 stop codon. Vice versa, studies reporting no disease association with the previously reported V/3 and C/3-BgllI RFLPs in Table 2 (except C/3-KpnI) cannot conclude that the V/318 polymorphisms are not involved in the disease susceptibility.
Physical mapping of the human and mouse TCR/3 gene complexes has shown a remarkable conservation in the organization of homologous V/3 genes between these two species (19, 25) . The human V/318 gene is most similar to the mouse V/314 gene based on the high nucleic acid homology between these gene segments (77%). Therefore, since the mouse V/314 has been shown to be the only V gene located 3' of the TCR/3 C region (26) , it was predicted that the human V/318 gene would be located 3' of the C region (19) . This was suggested by linkage disequilibrium (Table 2) and confirmed by isolating a cosmid that contained both the human V/318 and C region C/32 gene. Restriction enzyme and PCR mapping of this cosmid showed V/318 to be '~9 kb 3' of the C/32 gene segment. This 9-kb distance in humans is similar to the 10-kb distance between C/32 and V/314 in mice (26) . Multiple PCR analyses also showed that the human V/318 has an opposite transcriptional polarity relative to the TCR/3 D, J, and C region genes and other V/3 genes, as shown for mouse V/314 (26) . Thus, it may similarly be expected that human V/318 undergoes a chromosomal inversion to juxtapose V/318 with the D, J, and C region genes before successful transcription.
Since the human V/318 gene was originally cloned from an acute lymphocytic leukemia cell line (20) , and since it is 3' of C/3 as well as being polymorphic for a stop codon, it may be questioned as to the quantitative contribution of a functional V/318 protein product to the total TCR/3 repertoire. Choi et al. (27) estimated that V/318 (V/320 in their nomenclature) accounted for ~3.4% of the total V/3 expression after anti-CD3 stimulation of peripheral T cells from one individual, while another group failed to detect V/318 expression in peripheral blood from one donor (28) . V/318 is a single member subfamily (29) , so there are no other V/318 subfamily members that might subsume the role of V/318 and prevent this hole in the TCR repertoire caused by the null allele.
Our result showing greatly reduced (undetectable) V/318 RNA expression in the peripheral blood of the null allele in all eight individuals who possessed the null allele (Fig.  6, c and b) is consistent with the mechanisms of T cell selection that occur in the thymus. The positive or negative selection of T cells in the thymus is dependent on the specific ot and/3 proteins on the cell's surface. T cells that rearrange and transcribe the nonfunctional V/318 gene segment could not be positively selected because they would be unable to assemble a TCR a//3 protein heterodimer. Thus, these V/318-rearranged cells could not be expected to populate the peripheral blood and immune system to an appreciable level. In an individual homozygous for the VB18 null allele, a very low level of rearranged V/318 message in PBL could be accounted for by the infrequent additional rearrangement that can occur on the other chromosome 7 homologue in T cells that express some other V/3 gene on their cell surface. The failure to detect V/318-C/3 RNA message from the null allele is also consistent with what has been previously seen in mice with a similar V/3 stop codon (30, and see below [BALB/c v/3191).
While other polymorphic stop codons have not yet been reported in human TCR genes, there are two examples of polymorphic stop codons in mouse TCR V/3 genes. Mouse VB19 is expressed in the SJL strain, but the BALB/c strain has deleted a single base in the leader exon that results in a frameshift mutation (30) . A second example ofa polymorphic stop codon in a mouse TCR/3 gene is mouse V/317. Certain strains of mice possess a TCR fl haplotype that encodes a Vf117 gene with a single mutation in the coding region that results in a stop codon (31) . Other strains of mice with a functional Vf117 gene have their Vfl17-bearing T ceUs donally diminated in those mice that express a certain sdf-superantigen and the MHC class II molecule IE (32). Wade et al. 01) speculated that although self-tolerance mechanisms would seem to be able to control such autoimmune cells reactive to the sdf-superantigen, perhaps evolutionary pressures have acted to provide an additional means of eliminating such autoreac= tire T ceils from a portion of the population, via a stop codon. It is therefore interesting to note that the T ceils bearing human Vf118 appear to be stimulated by the Staphylococcus aureus enterotoxin superantigens (27) . This paraild between these mouse and human Vfl genes allows similar speculation on whether past sdective pressures on humans could have had an importance in the pm, alence of the polymorphic stop codon in the human Vf118 gene.
